0      0

Manufacturing Autologous Ex Vivo Genetically Modified Cell Therapies Have Challenges but the Future is Bright

Credits: None available.


  • S.Joseph Tarnowski, PhD, Senior Vice President, R&D, Medicinal Science & Technology, GlaxoSmithKline


Credits: None available.

You must be logged in and own this session in order to post comments.